Usha Medi-Soft Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.00 M
as on 24-10-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.91 Cr
as on 24-10-2024
- Revenue 37.10%
(FY 2023)
- Profit 105.13%
(FY 2023)
- Ebitda -19.89%
(FY 2023)
- Net Worth 126.72%
(FY 2023)
- Total Assets -1.27%
(FY 2023)
About Usha Medi-Soft
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹25.91 Cr.
Yerramreddy Rao and Usharani Yerramreddy serve as directors at the Company.
- CIN/LLPIN
U72200AP2000PTC035596
- Company No.
035596
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Usha Medi-Soft?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yerramreddy Rao  | Director | 03-Nov-2000 | Current |
| Usharani Yerramreddy | Director | 03-Nov-2000 | Current |
Financial Performance and Corporate Structure Insights of Usha Medi-Soft.
Usha Medi-Soft Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.1% increase. The company also saw a substantial improvement in profitability, with a 105.13% increase in profit. The company's net worth Soared by an impressive increase of 126.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Usha Medi-Soft?
In 2023, Usha Medi-Soft had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Keerti Bio Medica Private LimitedActive 19 years 30 days
Yerramreddy Rao and Usharani Yerramreddy are mutual person
- Usha Cardiac Centre LimitedActive 30 years 27 days
Yerramreddy Rao and Usharani Yerramreddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 21 Sep 2015 | ₹5.50 Cr | Open |
Syndicate Bank Creation Date: 09 Sep 2015 | ₹13.50 Cr | Open |
Vijaya Bank Creation Date: 27 Jun 2003 | ₹3.00 Cr | Open |
How Many Employees Work at Usha Medi-Soft?
Unlock and access historical data on people associated with Usha Medi-Soft, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Usha Medi-Soft, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Usha Medi-Soft's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
